Ettinger, S. and Mayer-Ferbas, J. and Jeindl, R. (2025): Serum eye drops for patients with severe ocular surface disease. Rapid Review Nr.: 017.

Colicchia, A. and Fabian, D. and Grabenhofer, L. and Grössmann-Waniek, N. and Malíková, E. and Rothschedl, E. and Sehic, O. and Wild, C. and Wolf, S. and Zechmeister-Koss, I. (2025): Fidanacogene elaparvovec (BEQVEZ®) for the treatment of moderately severe to severe haemophilia B. Decision Support Document for the Austrian Appraisal Board 002.

Grössmann-Waniek, N. and Wild, C. and Malíková, E. and Wolf, S. and Fabian, D. and Sehic, O. and Zechmeister-Koss, I. (2025): Exagamglogene autotemcel (Exa-cel, Casgevy®) for the treatment of beta-thalassaemia and severe sickle cell disease. Decision Support Document for the Austrian Appraisal Board 001.

AIHTA, HTA Austria (2025): Annual Report 2024.

Mayer-Ferbas, J. and Jeindl, R. (2025): Reimbursement models and pricing of digital health technologies and telemonitoring applications – Rapid scoping review. Rapid Review Nr.: 016.